Trifluoroacetic acid → HCID 178487407, compound
Reaction equation
[C:1]([C:4]1[CH:5]=[N:6][C:7]2[C:12]([C:13]=1[NH:14][C@H:15]1[CH2:20][CH2:19][C@H:18]([NH:21]C(=O)OC(C)(C)C)[CH2:17][CH2:16]1)=[CH:11][C:10]([C:29]1[CH:34]=[C:33]([O:35][CH3:36])[C:32]([OH:37])=[C:31]([Cl:38])[CH:30]=1)=[CH:9][CH:8]=2)(=[O:3])[CH3:2].C(O)(C(F)(F)F)=O>>[NH2:21][C@H:18]1[CH2:19][CH2:20][C@H:15]([NH:14][C:13]2[C:12]3[C:7](=[CH:8][CH:9]=[C:10]([C:29]4[CH:34]=[C:33]([O:35][CH3:36])[C:32]([OH:37])=[C:31]([Cl:38])[CH:30]=4)[CH:11]=3)[N:6]=[CH:5][C:4]=2[C:1](=[O:3])[CH3:2])[CH2:16][CH2:17]1Participants
3
Procedure
Following general procedure A-2, tert-butyl trans-4-[3-acetyl-6-(3-chloro-4-hydroxy-5-methoxyphenyl)quinolin-4-ylamino]cyclohexylcarbamate (35 mg, 0.065 mmol) was reacted with TFA (2 mL) to afford the desired product (13.6 mg, 48%) as an orange solid: 1H NMR (500 MHz, CD3OD) δ 8.95 (s, 1H), 8.32 (d, J=1.8 Hz, 1H), 8.04 (dd, J=8.7, 1.9 Hz, 1H), 7.92 (d, J=8.7 Hz, 1H), 7.27 (d, J=2.1 Hz, 1H), 7.22 (d, J=2.0 Hz, 1H), 4.23 (t, J=11.1 Hz, 1H), 3.99 (s, 3H), 3.24-3.16 (m, 1H), 2.70 (s, J=6.3 Hz, 3H), 2.41 (d, J=12.4 Hz, 2H), 2.18 (d, J=12.1 Hz, 2H), 1.80-1.66 (m, 2H), 1.61-1.50 (m, 2H); ESI MS m/z 440 [C24H26ClN3O3+H]+; HPLC 97.6% (AUC), tR=8.45 min.
Sources & evidence
- ORD record
- ord-8fd6f64b19184987a2dd25c8345abaac
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…